KYA1797K 25mg | ≥99%
CSNpharm
KYA1797K is a highly potent and selective Wnt/β-catenin inhibitor with IC50 of 0.75 µM (TOPflash assay).
More Information Supplier PageKYA1797K
Search Results
KYA1797K 1mg | ≥99%
CSNpharm
KYA1797K is a highly potent and selective Wnt/β-catenin inhibitor with IC50 of 0.75 µM (TOPflash assay).
More Information Supplier PageKYA1797K
KYA1797K 5mg | ≥99%
CSNpharm
KYA1797K is a highly potent and selective Wnt/β-catenin inhibitor with IC50 of 0.75 µM (TOPflash assay).
More Information Supplier PageKYA1797K
KYA1797K 10mg | ≥99%
CSNpharm
KYA1797K is a highly potent and selective Wnt/β-catenin inhibitor with IC50 of 0.75 µM (TOPflash assay).
More Information Supplier PageKYA1797K
KYA1797K 50mg | ≥99%
CSNpharm
KYA1797K is a highly potent and selective Wnt/β-catenin inhibitor with IC50 of 0.75 µM (TOPflash assay).
More Information Supplier PageKYA1797K
LTX-315 25mg | ≥99%
CSNpharm
LTX-315 is the oncolytic peptide that kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization.
More Information Supplier PageLTX-315
LTX-315 2mg | ≥99%
CSNpharm
LTX-315 is the oncolytic peptide that kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization.
More Information Supplier PageLTX-315
LTX-315 50mg | ≥99%
CSNpharm
LTX-315 is the oncolytic peptide that kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization.
More Information Supplier PageLTX-315
LTX-315 10mg | ≥99%
CSNpharm
LTX-315 is the oncolytic peptide that kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization.
More Information Supplier PageLTX-315
LTX-315 5mg | ≥99%
CSNpharm
LTX-315 is the oncolytic peptide that kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization.
More Information Supplier PageLTX-315
